EDGAR Filing Documents for 0001193125-12-234125

Form 10-Q - Quarterly report [Sections 13 or 15(d)]:

SEC Accession No. 0001193125-12-234125

Filing Date

2012-05-15

Accepted

2012-05-15 14:48:06

Documents

Period of Report

2012-03-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-Q	d338738d10q.htm	10-Q	196344
2	FIRST AMENDMENT STOCK PURCHASE AGREEMENT	d338738dex1040.htm	EX-10.40	12866
3	SECOND AMENDMENT TO STOCK PURCHASE AGREEMENT	d338738dex1041.htm	EX-10.41	12715
4	CERTIFICATION OF HENRY JI, PH.D., PRINCIPAL EXECUTIVE OFFICER	d338738dex311.htm	EX-31.1	7693
5	CERTIFICATION OF RICHARD GLENN VINCENT, PRINCIPAL FINANCIAL OFFICER	d338738dex312.htm	EX-31.2	6789
6	CERTIFICATION OF HENRY JI, PH.D., PRINCIPAL EXECUTIVE OFFICER, AND RICHARD GLENN	d338738dex321.htm	EX-32.1	8518
	Complete submission text file	0001193125-12-234125.txt		1019680

Data Files

Seq	Description	Document	Type	Size
7	XBRL INSTANCE DOCUMENT	srne-20120331.xml	EX-101.INS	74844
8	XBRL TAXONOMY EXTENSION SCHEMA	srne-20120331.xsd	EX-101.SCH	8858
9	XBRL TAXONOMY EXTENSION CALCULATION LINKBASE	srne-20120331_cal.xml	EX-101.CAL	21464
10	XBRL TAXONOMY EXTENSION LABEL LINKBASE	srne-20120331_lab.xml	EX-101.LAB	77045
11	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	srne-20120331_pre.xml	EX-101.PRE	51608

Mailing Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121

Business Address 6042 CORNERSTONE CT. WEST SUITE B SAN DIEGO CA 92121 858-210-3700

Sorrento Therapeutics, Inc. (Filer) CIK: 0000850261 (see all company filings)